Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
ClinQure, Inc. is a contract research organization (CRO) registered in Texas, USA, focusing on clinical quality and regulatory affairs for medical device and pharmaceutical R&D. Based on the captured content, it is not a typical SaaS or enterprise software product, but rather a professional-services-led outsourcing provider for clinical research, quality management systems, and regulatory submissions.
Its CRO services cover trial start-up, protocol and CRF development, informed consent, site feasibility and initiation, patient recruitment, project management, clinical monitoring, vendor and TMF management, IRB submissions, study closeout, data management, biostatistics, programming, and medical writing. On the QMS side, it offers gap assessments, SOP development, clinical research risk assessments, FDA inspection readiness, audit training, and MDSAP support. Its regulatory services include regulatory strategy, pre-submissions, Breakthrough Designation, 510(k), De Novo, PMA, MDR/IVDR technical documentation, export certificates, and GDPR compliance.
The website highlights upfront pricing and flexible budgeting, but does not publish packages, price lists, billing units, or service SLAs. Users need to schedule a meeting and discuss the project scope with experts to receive a custom quote. There also appears to be no free tier, trial, or online self-service purchase flow.
From an enterprise software perspective, ClinQure does not disclose information about cloud deployment, self-hosting, APIs, developer documentation, account permissions, or third-party software integrations. Phrases such as “Real-Time Study Status” and “Unified Collaboration” seem more like service commitments or project-management approaches than clearly defined software features. In terms of security and compliance, the text mentions professional compliance services related to FDA, MDSAP, MDR/IVDR, GDPR, IRB, and audit readiness, but does not provide platform security certifications such as SOC 2, ISO 27001, or HIPAA.
The main strengths are its broad service coverage across clinical trials, quality systems, and regulatory submissions, along with its emphasis on stable project managers, stable teams, efficiency, and customization. The drawbacks are limited transparency, with a lack of case studies, detailed qualifications, team background, pricing, and technical capability information. It is best suited for medical device, pharmaceutical, and life sciences companies seeking external expert support for clinical trial start-up, quality system remediation, FDA/MDR/IVDR submissions, and similar workstreams.
Access from mainland China, payment methods, and local delivery capabilities are not described in the text and should be considered unknown. If you need local clinical resources in China, Chinese-language delivery, and domestic regulatory communication, you may compare it with local CROs such as Tigermed, R&G PharmaStudies, and Pharmaron. International alternatives include IQVIA, ICON, Parexel, and Medpace.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on clinqure.com official site.
clinqure.com is an India SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach clinqure.com directly.